Use of Drug in a Difficult-to-Treat Disease Not Obvious Without Proof of Efficacy
OSI Pharma v. Apotex Inc. (Fed. Cir. 2019) In a decision issued recently, the Federal Circuit reversed the Patent Trial…
OSI Pharma v. Apotex Inc. (Fed. Cir. 2019) In a decision issued recently, the Federal Circuit reversed the Patent Trial…
Researchers from University of California, Berkeley (and related parties) and The Broad Institute, Inc. (and related parties) continue to battle…
Rule 90bis.1 provides an avenue for recourse if an applicant wishes to withdraw a filed international application in order to…
Unlike patents or trademarks, copyright protection automatically attaches to appropriate works once they are fixed in a tangible form. This…
The USPTO encourages Applicants to engage with Patent Examiners using Interview Practice. According to the USPTO website, “Interviews provide an…